CJ, L., P, S., E, M., T, v. W., B, B., J, S., . . . A, W. (2021). Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(24), 6737. https://doi.org/10.1158/1078-0432.CCR-21-1165
Chicago Style (17th ed.) CitationCJ, Lee, et al. "Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27, no. 24 (2021): 6737. https://doi.org/10.1158/1078-0432.CCR-21-1165.
MLA (9th ed.) CitationCJ, Lee, et al. "Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 24, 2021, p. 6737, https://doi.org/10.1158/1078-0432.CCR-21-1165.